These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3780850

  • 1. Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator of protein kinase C.
    Allgaier C, Von Kügelgen O, Hertting G.
    Eur J Pharmacol; 1986 Oct 07; 129(3):389-92. PubMed ID: 3780850
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline.
    Allgaier C, Hertting G, Huang HY, Jackisch R.
    Br J Pharmacol; 1987 Sep 07; 92(1):161-72. PubMed ID: 2822193
    [Abstract] [Full Text] [Related]

  • 3. Participation of protein kinase C and regulatory G proteins in modulation of the evoked noradrenaline release in brain.
    Hertting G, Allgaier C.
    Cell Mol Neurobiol; 1988 Mar 07; 8(1):105-14. PubMed ID: 2841025
    [Abstract] [Full Text] [Related]

  • 4. 3,4-Diaminopyridine-induced noradrenaline release from CNS tissue as a model for action potential-evoked transmitter release: effects of phorbol ester.
    Huang HY, Hertting G, Allgaier C, Jackisch R.
    Eur J Pharmacol; 1989 Oct 04; 169(1):115-23. PubMed ID: 2574686
    [Abstract] [Full Text] [Related]

  • 5. Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13-butyrate.
    Allgaier C, Hertting G.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 04; 334(2):218-21. PubMed ID: 3024034
    [Abstract] [Full Text] [Related]

  • 6. A selective effect of protein kinase C activators on noradrenaline release compared with subsequent contraction in canine isolated saphenous veins.
    Takata Y, Ozawa J, Kato H.
    Br J Pharmacol; 1991 Apr 04; 102(4):955-61. PubMed ID: 1855124
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phorbol esters potentiate rapid dopamine release from median eminence and striatal synaptosomes.
    Shu C, Selmanoff M.
    Endocrinology; 1988 Jun 04; 122(6):2699-709. PubMed ID: 3131121
    [Abstract] [Full Text] [Related]

  • 9. Protein kinase C activation increases noradrenaline release from the rat hippocampus and modifies the inhibitory effect of alpha 2-adrenoceptor and adenosine A1-receptor agonists.
    Fredholm BB, Lindgren E.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May 04; 337(5):477-83. PubMed ID: 2842695
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase C and alpha 2-adrenoceptor-mediated inhibition of noradrenaline release from the rat tail artery.
    Bucher B, Neuburger J, Illes P.
    J Cardiovasc Pharmacol; 1991 Jun 04; 17(6):913-5. PubMed ID: 1714014
    [Abstract] [Full Text] [Related]

  • 11. Phorbol ester-mediated enhancement of hippocampal noradrenaline release: which ion channels are involved?
    Huang HY, Allgaier C, Hertting G, Jackisch R.
    Eur J Pharmacol; 1988 Aug 24; 153(2-3):175-84. PubMed ID: 2460359
    [Abstract] [Full Text] [Related]

  • 12. Effect of phorbol esters on noradrenaline release from cerebral arteries.
    Balfagon G, Rosa de Sagarra M, Barrus MT, Arrivas S, Capilla MI, Marin J.
    Brain Res; 1989 Jan 16; 477(1-2):196-201. PubMed ID: 2564799
    [Abstract] [Full Text] [Related]

  • 13. Effect of K+ channel blockers on the alpha 2-adrenoceptor-coupled regulation of electrically evoked noradrenaline release in hippocampus.
    Allgaier C, Repp H, Hertting G.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan 16; 347(1):14-20. PubMed ID: 8383299
    [Abstract] [Full Text] [Related]

  • 14. The structural requirements for phorbol esters to enhance noradrenaline and dopamine release from rat brain cortex.
    Kotsonis P, Majewski H.
    Br J Pharmacol; 1996 Sep 16; 119(1):115-25. PubMed ID: 8872364
    [Abstract] [Full Text] [Related]

  • 15. A detailed study on the effects of protein kinase C activation on alpha-2 adrenoceptor-coupled modulation of norepinephrine release in hippocampus.
    Allgaier C, Hertting G, Singer EA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):143-8. PubMed ID: 1649291
    [Abstract] [Full Text] [Related]

  • 16. Staurosporine counteracts the phorbol ester-induced enhancement of neurotransmitter release in hippocampus.
    Daschmann B, Allgaier C, Nakov R, Hertting G.
    Arch Int Pharmacodyn Ther; 1988 Jul 01; 296():232-45. PubMed ID: 2907278
    [Abstract] [Full Text] [Related]

  • 17. [Adrenergic receptors regulation of insulin secretion due to 12-O-tetradecanoyl phorbol-13-acetate--a perifusion study].
    Kagawa S, Wakabayashi S, Yamashita K, Matsuoka A.
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul 20; 65(7):663-73. PubMed ID: 2555226
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of noradrenaline release by neuropeptide Y does not involve protein kinase C in mouse atria.
    Foucart S, Musgrave IF, Majewski H.
    Neuropeptides; 1990 Apr 20; 15(4):179-85. PubMed ID: 2259391
    [Abstract] [Full Text] [Related]

  • 19. Ionotropic glutamate receptor types leading to adenosine-mediated inhibition of electrically evoked [3H]-noradrenaline release in rabbit brain cortex slices.
    von Kügelgen I, Späth L, Starke K.
    Br J Pharmacol; 1993 Dec 20; 110(4):1544-50. PubMed ID: 7508327
    [Abstract] [Full Text] [Related]

  • 20. Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release.
    Allgaier C, Feuerstein TJ, Jackisch R, Hertting G.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov 20; 331(2-3):235-9. PubMed ID: 3003591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.